ANTABUSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Antabuse, and when can generic versions of Antabuse launch?
Antabuse is a drug marketed by Odyssey Pharms and Teva Womens and is included in three NDAs.
The generic ingredient in ANTABUSE is disulfiram. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the disulfiram profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Antabuse
A generic version of ANTABUSE was approved as disulfiram by SIGMAPHARM LABS LLC on March 28th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANTABUSE?
- What are the global sales for ANTABUSE?
- What is Average Wholesale Price for ANTABUSE?
Summary for ANTABUSE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 131 |
| Clinical Trials: | 25 |
| Patent Applications: | 3,264 |
| DailyMed Link: | ANTABUSE at DailyMed |
Recent Clinical Trials for ANTABUSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Universidad de Guanajuato | Early Phase 1 |
| Laboratorios Doctor Macías | Early Phase 1 |
| University of California, San Francisco | Phase 2 |
US Patents and Regulatory Information for ANTABUSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Odyssey Pharms | ANTABUSE | disulfiram | TABLET;ORAL | 088482-001 | Dec 8, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Womens | ANTABUSE | disulfiram | TABLET;ORAL | 007883-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Odyssey Pharms | ANTABUSE | disulfiram | TABLET;ORAL | 088483-001 | Dec 8, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Womens | ANTABUSE | disulfiram | TABLET;ORAL | 007883-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
